Schizophrenia Treatment Plan: Goals, Objectives, & Example for Mental Health Professionals

Treatment plans are one of the most important clinical documents completed in behavioral health. They provide a structured roadmap that connects a client’s diagnosis, symptoms, strengths, and treatment needs to measurable goals, evidence-based interventions, and ongoing progress monitoring. Because schizophrenia is a complex condition typically requiring coordinated medication management and psychosocial treatment, a well-written treatment plan helps ensure care remains intentional, collaborative, and closely coordinated across providers.

Creating an effective schizophrenia treatment plan involves much more than listing a few goals. It requires a comprehensive understanding of the client’s specific symptoms, functional impairment, medication response, support system, and the evidence-based approaches most likely to support recovery and stability. A strong treatment plan also demonstrates medical necessity, facilitates communication between providers, and creates objective benchmarks that make it easier to evaluate progress over time.

In this guide, we’ll walk through how to create an evidence-based schizophrenia treatment plan, discuss what information should be included, provide practical examples of treatment goals and objectives, and review common documentation considerations for mental health professionals. Whether you’re a student, intern, or experienced clinician, these examples can serve as a starting point for developing individualized treatment plans that reflect each client’s unique presentation.

Key Takeaways

• Schizophrenia treatment plans should be individualized. Effective plans connect the client’s specific symptoms, functional impairment, medication response, and support system to measurable goals rather than relying on generic documentation.
• DSM-5 eliminated schizophrenia subtypes, including “paranoid type,” in 2013. Prominent delusions or hallucinations should be documented descriptively as part of the current clinical presentation, not as a separate diagnostic category.
• Antipsychotic medication is first-line, foundational treatment for schizophrenia, and treatment plans should document medication management as central to care rather than as a secondary consideration.
• Treatment goals should follow SMART principles and connect to evidence-based approaches, including CBT and CBT adapted for psychosis (CBTp), coordinated specialty care, family intervention, and Individual Placement and Support (IPS) supported employment.
• Suicide risk is significantly elevated in schizophrenia, and comprehensive risk assessment should be an explicit, ongoing part of treatment planning rather than a one-time intake finding.

View our Counseling Treatment Plan Template, which corresponds with this guide.

Why Treatment Planning Matters for Schizophrenia

Schizophrenia is a chronic psychiatric condition that can significantly affect a person’s thoughts, perceptions, emotions, and ability to function, and it typically requires coordinated, long-term treatment involving multiple providers. While clients with schizophrenia often share common features—including positive symptoms such as delusions and hallucinations, negative symptoms such as diminished emotional expression or avolition, and cognitive difficulties—every client’s specific symptom pattern, functional impairment, and support system is different. Effective treatment planning helps clinicians organize assessment findings into a personalized course of treatment that reflects the client’s unique presentation rather than a generic symptom-management template.

A comprehensive treatment plan also serves several important clinical and administrative purposes. It supports continuity of care, promotes collaboration between psychiatric providers, therapists, case managers, and family members, documents medical necessity for third-party payers, and creates measurable outcomes that can be reviewed throughout treatment. Rather than functioning as a static document completed during intake, treatment plans should be reviewed and updated regularly as symptoms, medication response, and functioning change over time.

Whenever possible, treatment planning should be a collaborative process that respects the client’s preferences and goals. Involving clients in selecting meaningful goals often increases engagement and treatment adherence. Instead of focusing solely on symptom reduction, treatment plans should also build upon the client’s existing strengths and support system, and should reflect person-centered, recovery-oriented care.

Complete a Thorough Clinical Assessment Before Writing the Treatment Plan

A treatment plan should never be developed in isolation. Before identifying goals or selecting interventions, clinicians should complete a comprehensive assessment to better understand the client’s presenting concerns, psychiatric and medical history, current level of functioning, and diagnostic picture. Information gathered during the intake assessment provides the clinical foundation for every section of the treatment plan.

For clients presenting with possible schizophrenia, this assessment often includes a detailed clinical interview, psychiatric and medical history, substance use history, family psychiatric history, risk assessment, and, when possible, collateral information from family or other providers. Because psychotic symptoms can arise from a range of causes, clinicians should carefully rule out substance-induced psychosis, medical or neurological conditions, mood disorders with psychotic features, and other psychotic disorders before confirming a schizophrenia diagnosis. Clinicians should also evaluate how symptoms affect functioning across work or school, relationships, self-care, and independent living.

If you are looking for additional guidance on collecting assessment information before creating a treatment plan, our guides to the Counseling Intake Assessment and Biopsychosocial Assessment provide more detailed recommendations for conducting comprehensive evaluations.

Develop a Clinical Formulation Before Creating Treatment Goals

One of the most valuable steps in treatment planning is developing a clinical formulation before writing goals and objectives. While a diagnosis identifies what condition a client meets criteria for, a clinical formulation explains the client’s specific symptom presentation, functional impact, and the factors most relevant to their individual course of illness, and connects this understanding to why the selected interventions are appropriate.

An important starting point for formulation is diagnostic precision. DSM-5 eliminated the schizophrenia subtypes used in earlier editions—including paranoid, disorganized, catatonic, undifferentiated, and residual type—because they showed limited diagnostic stability, low reliability, and no consistent relationship to treatment response or outcome (American Psychiatric Association, 2022). “Paranoid schizophrenia” is not a current diagnosis; a client whose presentation centers on prominent delusions and hallucinations, often with relatively preserved cognitive and emotional functioning, should be documented as schizophrenia with that specific symptom presentation described directly, rather than assigned an outdated subtype label. Clinicians can still use dimensional severity ratings and applicable specifiers (such as catatonia, when present) to capture this heterogeneity.

Beyond diagnostic precision, formulation should consider the specific positive, negative, and cognitive symptoms present; the client’s insight into their illness; medication response and adherence history; substance use, which commonly co-occurs with schizophrenia; family and social support; and psychosocial stressors relevant to the current presentation. For example, if a client’s functional decline appears closely tied to medication nonadherence following a prior side-effect experience, formulation should address that specific barrier directly, connecting it to a treatment plan that addresses both the medication concern and the resulting functional impact.

Many treatment plans remain superficial because they list symptoms and interventions without explaining the clinical reasoning connecting the two. A strong formulation demonstrates why specific goals were prioritized, why certain interventions were selected, and how the client’s diagnosis, history, strengths, and support system influence the treatment approach.

Establish Medical Necessity Through Functional Impairment

Treatment plans should document more than the presence of psychotic symptoms. They should clearly explain how those symptoms interfere with functioning. Documenting clinically significant functional impairment can help support medical necessity determinations, but requirements vary by payer, jurisdiction, service type, and clinical setting, and documenting impairment alone does not automatically establish or guarantee medical necessity for every payer.

Rather than simply documenting that a client “has delusions,” describe the observable consequences of the client’s symptoms. Examples may include job loss connected to disorganized thinking or absenteeism, withdrawal from family relationships due to persecutory beliefs, inability to maintain independent housing, or hospitalization history connected to symptom exacerbation. These examples create a stronger clinical picture than documenting symptoms alone.

Whenever possible, establish a measurable baseline before treatment begins. A standardized symptom measure or clinician-rated severity scale, combined with documented functional status across relevant life domains, can assist clinicians in assessing severity and monitoring changes over time when used as part of a broader clinical evaluation.

Creating SMART Schizophrenia Treatment Goals

Effective treatment goals should be individualized, collaborative, and measurable. One of the most common documentation mistakes is writing goals that are too broad to evaluate objectively. Statements such as “reduce psychosis” or “improve functioning” provide little guidance for future treatment sessions and make it difficult to determine whether meaningful progress has occurred.

Instead, treatment goals should follow SMART principles whenever clinically appropriate. Goals should be specific, measurable, achievable, relevant, and time-bound. Objectives should identify observable behaviors or changes that demonstrate movement toward the larger treatment goal.

Breaking larger goals into smaller objectives also allows clinicians to recognize incremental progress throughout treatment. These measurable objectives become valuable reference points during treatment plan reviews and progress note documentation.

Schizophrenia Treatment Goal Examples

The following schizophrenia treatment goal examples are designed to help mental health professionals develop individualized treatment plans based on each client’s diagnosis, symptoms, functional impairment, strengths, and treatment needs. Effective treatment goals should be collaborative, measurable, and connected to specific objectives and interventions that support meaningful clinical progress. These examples can be adapted based on the client’s specific symptom presentation and treatment setting.

Goal 1: Support Medication Stability and Symptom Management

Long-Term Goal: Client will maintain consistent medication adherence and demonstrate improved management of positive symptoms.

Possible Objectives:

• Attend scheduled psychiatric and therapy appointments consistently.
• Take prescribed medication as directed, tracked via pill organizer or medication log.
• Identify and report medication side effects to the prescribing provider in a timely manner.
• Practice at least one coping strategy for managing distress connected to hallucinations or delusions.

Possible Interventions:

• Coordination with the prescribing provider regarding medication response and side effects.
• Psychoeducation regarding schizophrenia and the role of medication in treatment.
• CBT for psychosis (CBTp) targeting distress and coping related to persistent symptoms.
• Routine progress monitoring of symptom severity and functioning.

Goal 2: Improve Daily Functioning and Independent Living Skills

Long-Term Goal: Client will demonstrate improved ability to manage daily responsibilities and increase independence.

Possible Objectives:

• Identify and practice one specific self-care or household task weekly, tracked via self-report.
• Develop and follow a basic daily structure or routine.
• Identify and access at least one community resource relevant to independent living needs.
• Report increased confidence in managing a specific daily responsibility, reviewed in session.

Possible Interventions:

• Skills training targeting specific functional deficits.
• Case management or care coordination connecting the client to community resources.
• Cognitive remediation targeting attention, memory, or executive functioning as clinically indicated.
• Collaborative goal-setting focused on the client’s own priorities for independence.

Goal 3: Increase Social Connection and Family Support

Long-Term Goal: Client will increase engagement in social relationships and strengthen the family’s capacity to provide effective support.

Possible Objectives:

• Attend at least one identified social, vocational, or peer support activity weekly.
• Practice a specific communication strategy in at least one family interaction weekly.
• Family members will attend psychoeducation sessions regarding schizophrenia and effective communication strategies.
• Identify and reduce a specific source of family conflict connected to symptom-related behaviors.

Possible Interventions:

• Social skills training targeting specific interpersonal goals.
• Family psychoeducation and communication skills training.
• Supported employment or vocational services as clinically indicated.
• Coordination with peer support or community-based programs.

Remember that these examples are intended as starting points rather than standardized treatment plans. Effective treatment planning requires ongoing collaboration with the client and should reflect their diagnosis, symptoms, strengths, cultural considerations, and treatment preferences. Objectives, interventions, and review dates should be modified as the client makes progress or new treatment priorities emerge.

What to Include in a Schizophrenia Treatment Plan

A comprehensive schizophrenia treatment plan should do more than identify symptoms and list interventions. Effective treatment planning creates a clinical roadmap that connects the client’s diagnosis, presenting concerns, functional impairment, strengths, treatment goals, measurable objectives, and selected interventions.

While treatment plan requirements vary depending on clinical setting, payer expectations, state regulations, and organizational policies, many evidence-informed treatment plans include several core elements that support clinical decision-making, continuity of care, and ongoing measurement of treatment progress.

A comprehensive schizophrenia treatment plan template typically includes the following clinical documentation sections:

The following sections provide a detailed overview of each component and explain how clinicians can use these elements to create treatment plans that are clinically meaningful, individualized, and responsive to client needs.

1. Client and Plan Information

The first section establishes essential identifying and administrative information while creating a clear record of the treatment episode. Clinicians typically document client information, treatment plan dates, review dates, plan type, clinician information, practice details, session format, session frequency, and the anticipated duration of treatment.

Documenting this information helps establish when treatment began, who is responsible for care, how frequently services are provided, and when the plan should be reviewed. A treatment plan should be considered a living clinical document that changes as symptoms, medication response, and functioning evolve over time.

2. Coordinating Providers and Services

Schizophrenia treatment typically involves multiple providers, and this section is often especially important given the central role of medication management. This section documents the prescribing psychiatric provider, primary care provider, case manager, and any other agencies or professionals involved in the client’s care, along with relevant releases of information (ROIs) and plans for coordination.

Close coordination between the therapist and prescribing provider supports a shared understanding of symptom status, medication response, and treatment priorities, and helps ensure that psychosocial and pharmacological treatment are working toward the same goals.

3. Diagnostic Summary

The diagnostic summary documents the client’s current diagnosis, applicable ICD-10-CM code, diagnostic considerations, and clinical evidence supporting the diagnosis, consistent with DSM-5-TR criteria (American Psychiatric Association, 2022). F20.9 represents unspecified schizophrenia in ICD-10-CM; clinicians should verify the current ICD-10-CM code set for the specific presentation and any applicable specifiers rather than treating F20.9 as the universal code for every case. Diagnostic criteria require at least two of five characteristic symptoms (delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and negative symptoms) present for a significant portion of a one-month period, with at least one of the two required symptoms being delusions, hallucinations, or disorganized speech; continuous signs of disturbance for at least six months, including at least one month of active-phase symptoms; and a decline in functioning in one or more major areas (work, interpersonal relations, or self-care) since onset (American Psychiatric Association, 2022).

As discussed in the formulation section above, DSM-5 removed the previous subtypes of schizophrenia—including “paranoid type”—in 2013. A strong diagnostic summary documents the client’s specific current symptoms directly (for example, prominent persecutory delusions and auditory hallucinations) rather than using an outdated subtype label, and should note relevant rule-outs, including substance-induced psychosis, mood disorders with psychotic features, and other psychotic disorders, along with any co-occurring conditions such as a substance use disorder, which is common among individuals with schizophrenia.

4. Clinical Formulation and Treatment Rationale

Clinical formulation is one of the most important components of a comprehensive treatment plan because it explains the clinician’s understanding of the client’s specific presentation and why particular treatment approaches were selected. Rather than documenting isolated symptoms, clinicians should synthesize the client’s positive, negative, and cognitive symptoms, insight into their illness, medication history, and relevant psychosocial factors.

This section should also identify the client’s existing strengths and resources—periods of stability, medication adherence when supported appropriately, engaged family members, prior vocational or educational success, or personal interests and goals—alongside realistic barriers that may interfere with treatment participation or progress, such as limited insight into the illness, side-effect concerns affecting medication adherence, co-occurring substance use, or limited social support. A strong formulation demonstrates why specific goals were prioritized, why certain interventions were selected, and how the client’s diagnosis, history, strengths, and support system influence the treatment approach.

5. Medication and Concurrent Treatment

Antipsychotic medication is first-line, foundational treatment for schizophrenia, and this section should reflect that centrality rather than treating medication as a secondary consideration. Document current medications, dosages, prescribing providers, treatment response, adherence, and side effects. When a client’s symptoms have improved with a given antipsychotic medication, continuing that medication is generally recommended; when a client has treatment-resistant symptoms or is at elevated risk for suicide or aggression despite other treatments, clozapine may be recommended by the prescribing provider (Keepers et al., 2020).

This section may also include other concurrent treatments such as primary care, substance use treatment, or other medical services. Documenting concurrent services provides a more complete picture of the client’s treatment landscape and supports coordinated clinical decision-making between the therapist and prescribing provider.

6. Presenting Problems and Functional Impact

The presenting problems section describes the client’s primary concerns and explains how symptoms interfere with daily functioning. Effective documentation goes beyond stating that a client “has schizophrenia” by describing how specific positive, negative, and cognitive symptoms interfere with important areas of life.

Clinicians may document impairment related to employment or school, relationships, self-care, independent living, and safety. Whenever possible, documentation should include observable examples of impairment. For example, noting a specific job loss connected to disorganized thinking, or documented withdrawal from family relationships tied to persecutory beliefs, provides stronger clinical evidence than documenting symptoms alone.

7. Treatment Goals and Objectives

Treatment goals identify the primary clinical outcomes the client and clinician are working toward throughout treatment. Effective schizophrenia treatment goals should be individualized, clinically meaningful, and connected to the client’s specific symptoms and functional priorities.

Each goal should include its own baseline severity and current functioning—the client’s starting point on relevant symptom measures and functional indicators. Establishing this reference allows clinicians to evaluate whether interventions are producing meaningful improvement over time. Short-term objectives then break the larger goal into measurable steps, describing observable changes in symptoms, medication adherence, or functioning. Each goal should also document the specific interventions being used to pursue it and the clinical rationale connecting those interventions to the client’s diagnosis, formulation, and presentation, along with how progress toward that goal will be tracked over time.

8. Treatment Modality and Interventions

This section identifies the specific interventions being used and explains how those approaches support the client’s treatment goals. Interventions should be selected based on the client’s specific presentation, preferences, and treatment needs rather than applied as a fixed protocol, and should be understood as distinct types of care rather than interchangeable “modalities”:

• Pharmacological treatment: antipsychotic medication, coordinated with the prescribing provider rather than managed by the therapist directly (Keepers et al., 2020).
• Psychotherapy: CBT, particularly CBT adapted for psychosis (CBTp), which addresses distress associated with hallucinations, delusions, and unusual experiences, along with coping strategies, beliefs about symptoms, behavioral responses, and functioning; standard CBT and CBTp are both identified as appropriate psychosocial interventions and neither should be characterized as ineffective (Department of Veterans Affairs & Department of Defense, 2023; National Institute for Health and Care Excellence, 2014/2025).
• Family intervention: a specific, evidence-based intervention involving psychoeducation, communication skills, negotiated problem-solving, and relapse and crisis planning—not simply general family support—strongly associated with reduced relapse and hospitalization when the client consents to family involvement (Department of Veterans Affairs & Department of Defense, 2023).
• Early-intervention service model: coordinated specialty care, a team-based model particularly relevant to first-episode psychosis that integrates psychotherapy, family psychoeducation, medication management, case management, and supported employment or education within a single coordinated program, rather than representing a single psychotherapy technique (Keepers et al., 2020).
• Intensive community treatment: assertive community treatment (ACT), an intensive, team-based community service model appropriate for clients with severe functional impairment, repeated hospitalizations, or a pattern of low engagement with services—not a routine intervention for every client with schizophrenia (Department of Veterans Affairs & Department of Defense, 2023).
• Cognitive rehabilitation: cognitive remediation, targeting attention, memory, or executive functioning when cognitive symptoms are clinically significant.
• Vocational rehabilitation: Individual Placement and Support (IPS), the evidence-based supported employment model, particularly relevant when the client has identified an employment goal; not every vocational service follows the IPS model specifically (Department of Veterans Affairs & Department of Defense, 2023).
• Functional and social interventions: social skills training, supported education when education is a treatment goal, self-management and recovery-oriented interventions, and peer support.

Treatment for co-occurring conditions, including substance use disorders, should also be addressed directly when present.

This section should also document between-session assignments designed to extend therapeutic work beyond scheduled appointments, such as practicing an identified coping strategy for distressing symptoms, following a medication routine, or completing a specific skills-training task.

9. Risk Assessment and Safety Planning Summary

Comprehensive risk assessment is a particularly important component of schizophrenia treatment planning. People with schizophrenia have substantially elevated suicide risk compared with the general population, and this risk should be assessed on an individualized basis rather than assumed absent because a client appears clinically stable (Keepers et al., 2020). A treatment plan does not replace a comprehensive risk assessment or standalone safety plan, but this section should summarize relevant findings.

This section may include current and historical suicidal ideation, self-harm concerns, homicidal ideation, aggression risk, substance use, command hallucinations or delusions with safety implications, protective factors, overall risk level, and whether a separate safety plan has been completed. Risk should be reassessed whenever clinically appropriate, including following significant symptom changes, medication changes, psychiatric hospitalization, or changes in functioning, rather than treated as a one-time intake finding.

10. Family, Support, and Collateral Involvement

Family involvement can play a significant role in schizophrenia treatment when it aligns with the client’s preferences and clinical needs. Treatment plans may document family participation preferences, collateral contacts, community resources, peer support programs, cultural considerations, and other external resources.

Evidence-based family intervention is more specific than general family support: it typically includes psychoeducation, communication skills work, negotiated problem-solving, and relapse or crisis planning, and is strongly recommended given its association with reduced relapse and hospitalization (Department of Veterans Affairs & Department of Defense, 2023). Involving family members—when the client consents and when clinically appropriate—can improve understanding of the illness, reduce relational conflict connected to symptoms, and strengthen the client’s overall support system. All collateral involvement should follow informed consent and confidentiality requirements.

11. Transition and Discharge Planning

Transition planning helps clinicians and clients identify what successful treatment progress may look like and establish criteria for moving toward discharge or a lower level of care. Because schizophrenia is typically a chronic condition, discharge criteria should reflect realistic markers of stability and improved functioning rather than the complete absence of symptoms, and treatment often involves long-term maintenance care and step-down planning rather than a fixed endpoint.

Aftercare planning may include continued medication management, referrals to community mental health resources, supported housing or employment services, peer support programs, or a clear relapse-prevention plan identifying early warning signs and steps to take if symptoms begin to escalate.

12. Plan Review and Signatures

The final section documents treatment plan review, client participation, signatures, and required approvals. Including client participation reinforces that treatment planning is a collaborative process developed between the client and clinician; when insight or capacity concerns are present, documentation should reflect how the client’s preferences were incorporated to the greatest extent possible, and how family or guardian involvement, if applicable, was addressed consistent with legal and ethical requirements.

Documenting signatures, review dates, updates, and progress summaries provides a clear record that the treatment plan has been discussed, evaluated, and modified as clinically appropriate throughout treatment.

Schizophrenia Treatment Plan Example

The following example demonstrates how the clinical sections of a schizophrenia treatment plan connect together for a client presenting with prominent persecutory delusions and auditory hallucinations. This example follows the clinical structure of the TherapyByPro Counseling Treatment Plan template, including diagnostic summary, clinical formulation, functional impairment, measurable treatment goals, baseline severity, treatment objectives, evidence-based interventions, clinical rationale, risk assessment, and progress monitoring.

This example is provided for educational purposes only and should be adapted based on the individual client’s symptoms, diagnosis, treatment preferences, clinical judgment, practice setting, and applicable documentation requirements.

Schizophrenia Treatment Plan Template

The images below provide a preview of TherapyByPro’s Counseling Treatment Plan template, designed for mental health professionals who need a structured framework for documenting schizophrenia treatment goals, measurable objectives, clinical formulation, interventions, risk considerations, and treatment progress.

The template follows a comprehensive clinical structure that can be adapted for clients across the range of schizophrenia presentations, including those with co-occurring substance use, depression, or other conditions. It includes sections for client and plan information, care coordination, diagnostic summary, clinical formulation, medication and concurrent treatment, presenting problems and functional impairment, treatment goals, objectives, interventions, treatment modality, risk assessment, family and support involvement, discharge planning, and plan review documentation.

Organized across 15 dedicated pages, the editable Word document and fillable PDF allow clinicians to customize documentation based on their practice setting, clinical approach, and documentation requirements while maintaining a consistent treatment planning workflow.

Clinicians seeking a complete treatment planning solution can access TherapyByPro’s Counseling Treatment Plan template. For clinicians who need a streamlined tool focused specifically on documenting treatment goals, objectives, and interventions, the Treatment Plan Goals template provides a simplified format for tracking progress across multiple treatment goals.

Common Documentation Mistakes When Writing a Treatment Plan for Schizophrenia

Even experienced clinicians can develop documentation habits that reduce the clinical usefulness of a schizophrenia treatment plan. A strong treatment plan should do more than identify that a client “has psychosis”—it should explain the client’s specific symptom pattern, functional impairment, treatment goals, selected interventions, and measurable indicators of progress.

The following examples highlight common schizophrenia treatment planning mistakes, why they create documentation challenges, and how clinicians can strengthen their documentation approach.

Clinical Note: One of the most common documentation challenges in schizophrenia treatment planning is describing symptoms without connecting them to functional impairment, medication status, and an individualized risk assessment. A strong schizophrenia treatment plan connects the client’s specific symptom presentation, functional impairment, coordinated medication management, treatment goals, interventions, and measurable outcomes into a cohesive clinical roadmap.

Conclusion: Creating Effective Schizophrenia Treatment Plans That Support Meaningful Clinical Progress

An effective schizophrenia treatment plan is more than a documentation requirement. It connects the client’s specific symptom presentation, functional impairment, and coordinated medication management with evidence-based psychosocial interventions designed to support recovery and stability.

Current guidelines emphasize a documented, comprehensive, person-centered treatment plan that includes both evidence-based pharmacological and nonpharmacological treatments (Keepers et al., 2020). Because schizophrenia is typically a chronic condition, treatment plans are especially important as living documents, reviewed and updated as symptoms, medication response, and functioning evolve over the course of long-term care.

References

• American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed., text revision; DSM-5-TR). American Psychiatric Association Publishing. Resource
• Department of Veterans Affairs & Department of Defense. (2023). VA/DoD clinical practice guideline for the management of first-episode psychosis and schizophrenia (Version 1.0). Resource
• Keepers, G. A., Fochtmann, L. J., Anzia, J. M., Benjamin, S., Lyness, J. M., Mojtabai, R., Servis, M., Walaszek, A., Buckley, P., Lenzenweger, M. F., Young, A. S., Degenhardt, A., & Hong, S. H. (2020). The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. American Journal of Psychiatry, 177(9), 868–872. Resource
• National Institute for Health and Care Excellence. (2014, updated 2025). Psychosis and schizophrenia in adults: Prevention and management (NICE guideline CG178). Resource